Vanguard Group’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.04M | Buy |
1,787,549
+51,445
| +3% | +$260K | ﹤0.01% | 2956 |
|
|
2025
Q1 | $9.81M | Buy |
1,736,104
+396,954
| +30% | +$2.24M | ﹤0.01% | 2854 |
|
|
2024
Q4 | $11.6M | Buy |
1,339,150
+392,885
| +42% | +$3.41M | ﹤0.01% | 2871 |
|
|
2024
Q3 | $6.56M | Buy |
946,265
+127,715
| +16% | +$885K | ﹤0.01% | 3155 |
|
|
2024
Q2 | $5.08M | Buy |
818,550
+277,255
| +51% | +$1.72M | ﹤0.01% | 3261 |
|
|
2024
Q1 | $855K | Buy |
541,295
+115,546
| +27% | +$183K | ﹤0.01% | 3862 |
|
|
2023
Q4 | $626K | Buy |
425,749
+21,680
| +5% | +$31.9K | ﹤0.01% | 3968 |
|
|
2023
Q3 | $372K | Sell |
404,069
-1,686
| -0.4% | -$1.55K | ﹤0.01% | 4139 |
|
|
2023
Q2 | $511K | Hold |
405,755
| – | – | ﹤0.01% | 4115 |
|
|
2023
Q1 | $548K | Hold |
405,755
| – | – | ﹤0.01% | 4102 |
|
|
2022
Q4 | $726K | Buy |
405,755
+294
| +0.1% | +$526 | ﹤0.01% | 4004 |
|
|
2022
Q3 | $1.27M | Hold |
405,461
| – | – | ﹤0.01% | 3924 |
|
|
2022
Q2 | $1.31M | Sell |
405,461
-1,695
| -0.4% | -$5.49K | ﹤0.01% | 3995 |
|
|
2022
Q1 | $2.07M | Sell |
407,156
-8,197
| -2% | -$41.7K | ﹤0.01% | 3942 |
|
|
2021
Q4 | $3.25M | Buy |
415,353
+201,773
| +94% | +$1.58M | ﹤0.01% | 3840 |
|
|
2021
Q3 | $2.32M | Buy |
+213,580
| New | +$2.32M | ﹤0.01% | 4017 |
|